FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / SPONSORED ADS
Total 13F shares
9,975,309
Share change
+9,975,309
Total reported value
$154,754,000
Price per share
$15.61
Number of holders
22
Value change
+$154,754,000
Number of buys
22

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q3 2020

As of 30 Sep 2020, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,975,309 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, CHI Advisors LLC, Sectoral Asset Management Inc, Polygon Management Ltd., Novo Holdings A/S, FRAZIER MANAGEMENT LLC, AXA S.A., FIL Ltd, and Woodline Partners LP. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.